One of the biggest challenges when evaluating BPC-157 safety is the limited availability of large-scale human clinical trials
Warning Do not use vitamin 12 injection if you are allergic to vitamin b12 or cobalt
*Correspondence: Manuel Ruiz-Pablos, [email protected]
This is a much larger quantity than most peptides and creates unique challenges
Maitane Prez Argeso 1 , Nagore del Molino Urquijo 1 , Sal Silvarrey Rodrguez 1 , Begoa Huete Antn 1 , Juan Manuel Garcia Sanchez 1 , Borja Aguilera Irazabal 1 , Naroa Arenaza Basterrechea 1 , Juan Carlos Garca-Monco Carra 1 1 Hospital Universitario de Basurto, Bilbao, Spain Background and Aims: Mechanical thrombectomy (MT) has demonstrated significant benefits in patients meeting strict ESOC guidelines criteria: mRS1, large vessel occlusion (internal carotid artery, M1 segment of the middle cerebral artery or basilar artery), NIHSS6, ASPECTS6 and a door-to-needle time 6 hours or 24 hours with a favourable mismatch on multimodal CT